跳至主要内容
临床试验/NL-OMON36756
NL-OMON36756已完成不适用

A Single dose, two-way crossover study of the bioequivalence of two formulations of Ribavirin - BE of Ribavirin

Schering-Plough0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 18-55 years,
  • BMI 18-30 kg/m2 (inclusive)
  • man or postmenopausal women

排除标准

  • Suffering from: hepatitis B, cancer or HIV/Aids. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood (for men) / more than 1.0 liters of blood (for women) in the 10 months preceding the start of this study.

研究者

发起方
Schering-Plough

相似试验